Personal profile
Headline
PROFESSORIAL LECTURER
Fingerprint
Dive into the research topics where Kurt Hirschhorn is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
A Conversation with Kurt and Rochelle Hirschhorn
Hirschhorn, K., Hirschhorn, R. & Hirschhorn, J. N., 31 Aug 2017, In: Annual Review of Genomics and Human Genetics. 18, p. 31-44 14 p.Research output: Contribution to journal › Review article › peer-review
Open Access3 Scopus citations -
Institutional profile: Translational pharmacogenomics at the Icahn School of Medicine at Mount Sinai
Scott, S. A., Owusu Obeng, A., Botton, M. R., Yang, Y., Scott, E. R., Ellis, S. B., Wallsten, R., Kaszemacher, T., Zhou, X., Chen, R., Nicoletti, P., Naik, H., Kenny, E. E., Vega, A., Waite, E., Diaz, G. A., Dudley, J., Halperin, J. L., Edelmann, L. & Kasarskis, A. & 8 others, , Oct 2017, In: Pharmacogenomics. 18, 15, p. 1381-1386 6 p.Research output: Contribution to journal › Article › peer-review
Open Access17 Scopus citations -
2013 Victor A. McKusick Leadership Award Addresses1
Hirschhorn, K. & Hirschhorn, R., 6 Mar 2014, In: American Journal of Human Genetics. 94, 3, p. 336-337 2 p.Research output: Contribution to journal › Comment/debate
Open Access1 Scopus citations -
Immunodeficiency Disorders
Hirschhorn, R., Hirschhorn, K. & Notarangelo, L. D., 1 Jan 2013, Emery and Rimoin's Principles and Practice of Medical Genetics. Elsevier, p. 1-30 30 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
-
Tetrasomy 15q26: A distinct syndrome or Shprintzen-Goldberg syndrome phenocopy?
Levy, B., Tegay, D., Papenhausen, P., Tepperberg, J., Nahum, O., Tsuchida, T., Pletcher, B. A., Ala-Kokko, L., Baker, S., Frederick, B., Hirschhorn, K., Warburton, P. & Shanske, A., Sep 2012, In: Genetics in Medicine. 14, 9, p. 811-818 8 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations
Press/Media
-
End-of-Quarter Synopsis Monthly : Rapt Therapeutics (RAPT: $33.87) increases, 2 months' volume in a month
31/12/25
1 item of Media coverage
Press/Media
-
Rapt Therapeutics soars 179% in 2025, outperforming Pharmaceuticals sector
12/12/25
1 item of Media coverage
Press/Media
-
Early Exposure to Peanuts Can Help Reduce the Risk of Developing Allergies in Children
Hirschhorn, K., Sampson, H. & Sicherer, S.
2/12/25
1 item of Media coverage
Press/Media
-
Rapt Therapeutics continues uptrend, soars 163% and in top 4% of the market
28/11/25
1 item of Media coverage
Press/Media
-
Weekly Summary: Rapt Therapeutics (RAPT: $27.08) keeps sliding: down 10% in 3 weeks; -$1.77 [6.1%]
22/11/25
1 item of Media coverage
Press/Media